ENTO
Price
$0.38
Change
-$0.06 (-13.64%)
Updated
Jun 27 closing price
Capitalization
1.76M
GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
4.51M
Interact to see
Advertisement

ENTO vs GENFF

Header iconENTO vs GENFF Comparison
Open Charts ENTO vs GENFFBanner chart's image
Entero Therapeutics
Price$0.38
Change-$0.06 (-13.64%)
Volume$442.26K
Capitalization1.76M
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$1K
Capitalization4.51M
ENTO vs GENFF Comparison Chart in %
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTO vs. GENFF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a Buy and GENFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ENTO: $0.38 vs. GENFF: $0.01)
Brand notoriety: ENTO and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 28% vs. GENFF: 24%
Market capitalization -- ENTO: $1.81M vs. GENFF: $4.51M
ENTO [@Biotechnology] is valued at $1.81M. GENFF’s [@Biotechnology] market capitalization is $4.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTO is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 5 TA indicator(s) are bullish while GENFF’s TA Score has 2 bullish TA indicator(s).

  • ENTO’s TA Score: 5 bullish, 5 bearish.
  • GENFF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ENTO is a better buy in the short-term than GENFF.

Price Growth

ENTO (@Biotechnology) experienced а -28.63% price change this week, while GENFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GENFF($4.51M) has a higher market cap than ENTO($1.76M). ENTO YTD gains are higher at: -39.068 vs. GENFF (-81.095).
ENTOGENFFENTO / GENFF
Capitalization1.76M4.51M39%
EBITDA-7.42MN/A-
Gain YTD-39.068-81.09548%
P/E Ratio0.03N/A-
Revenue0N/A-
Total Cash59.4KN/A-
Total Debt836KN/A-
FUNDAMENTALS RATINGS
ENTO: Fundamental Ratings
ENTO
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTOGENFF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
40%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
50%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
33%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
44%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PED0.670.01
+1.31%
PEDEVCO Corp
MED13.570.15
+1.12%
Medifast
EPAM174.930.93
+0.53%
Epam Systems
CRTO23.830.02
+0.08%
Criteo SA
AKAN1.45N/A
N/A
Akanda Corp

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
-12.87%
IVVD - ENTO
65%
Loosely correlated
N/A
FBLG - ENTO
37%
Loosely correlated
-13.19%
RLMD - ENTO
36%
Loosely correlated
N/A
CABA - ENTO
30%
Poorly correlated
-6.52%
GENFF - ENTO
25%
Poorly correlated
N/A
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and OTLK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
OTLK - GENFF
25%
Poorly correlated
-8.57%
ENTO - GENFF
25%
Poorly correlated
-12.87%
CAPR - GENFF
25%
Poorly correlated
+9.53%
APLIF - GENFF
24%
Poorly correlated
-1.90%
TOVX - GENFF
24%
Poorly correlated
-2.32%
More